CD123, the plasmacytoid dendritic cell phenotypic marker, is abundant in leprosy type 1 reaction

British Journal of Dermatology

Volumn 172, Issue 1, 2015, Pages 268-271

  Andrade, P R ^a   Amadeu, T P ^b   Nery, J A ^a   Pinheiro, R O ^a   Sarno, E N ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CD123 ANTIGEN; CD163 ANTIGEN; INTERLEUKIN 3; MESSENGER RNA; TOLL LIKE RECEPTOR 2; BIOLOGICAL MARKER;

CELL POPULATION; DISEASE COURSE; FLOW CYTOMETRY; GENE EXPRESSION; GRANULOMA; HUMAN; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; LEPROSY; LEPROSY TYPE 1 REACTION; LETTER; PHENOTYPE; PLASMACYTOID DENDRITIC CELL; PRIORITY JOURNAL; SKIN DEFECT; BACTERIAL SKIN DISEASE; DENDRITIC CELL; IMMUNOLOGY; METABOLISM; SKIN;

BIOLOGICAL MARKERS; DENDRITIC CELLS; HUMANS; INTERLEUKIN-3; INTERLEUKIN-3 RECEPTOR ALPHA SUBUNIT; LEPROSY; SKIN; SKIN DISEASES, BACTERIAL;

EID: 84920836185     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/bjd.13430     Document Type: Letter

References (12)

1. Walker SL, Lockwood DNJ,. Leprosy type 1 (reversal) reactions and their management. Lepr Rev 2008; 79: 372-86.
2. Kar BR, Job CK,. Reversal reaction and Mitsuda conversion in polar lepromatous leprosy: a case report. Lepr Rev 2005; 76: 258-62.
3. Yamamura M, Uyemura K, Deans RJ, et al,. Defining protective responses to pathogens: cytokine profiles in leprosy lesions. Science 1991; 254: 277-9.
4. Turk JL, Narayanan RB,. The origin, morphology, and function of epithelioid cells. Immunobiology 1982; 161: 274-82.
5. Facchetti F, Vermi W,. Plasmacytoid monocytes and plasmacytoid dendritic cells. Immune system cells linking innate and acquired immunity. Pathologica 2002; 94: 163-75.
6. Facchetti F, Candiago E, Vermi W,. Plasmacytoid monocytes express IL3-receptor alpha and differentiate into dendritic cells. Histopathology 1999; 35: 88-9.
7. Dzionek A, Fuchs A, Schmidt P, et al,. BDCA-2, BDCA-3, and BDCA-4: three markers for distinct subsets of dendritic cells in human peripheral blood. J Immunol 2000; 165: 6037-46.
8. Massone C, Nunzi E, Ribeiro-Rodrigues R, et al,. T regulatory cells and plasmocytoid dentritic cells in hansen disease: a new insight into pathogenesis? Am J Dermatopathol 2010; 32: 251-6.
9. Moura DF, de Mattos KA, Amadeu TP, et al,. CD163 favors Mycobacterium leprae survival and persistence by promoting anti-inflammatory pathways in lepromatous macrophages. Eur J Immunol 2012; 42: 2925-36.
10. Niemeyer CM, Sieff CA, Mathey-Prevot B, et al,. Expression of human interleukin-3 (multi-CSF) is restricted to human lymphocytes and T-cell tumor lines. Blood 1989; 73: 945-51.
11. Farkas L, Beiske K, Lund-Johansen F, et al,. Plasmacytoid dendritic cells (natural interferon- α/β-producing cells) accumulate in cutaneous lupus erythematosus lesions. Am J Pathol 2001; 159: 237-43.
12. Gilliet M, Conrad C, Geiges M, et al,. Psoriasis triggered by toll-like receptor 7 agonist imiquimod in the presence of dermal plasmacytoid dendritic cell precursors. Arch Dermatol 2004; 140: 1490-5.